Clinical Trial Update: A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of BTD-001 in idiopathic hypersomnia and narcolepsy type 2 (narcolepsy without cataplexy) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia
• Narcolepsy Without Cataplexy

Drugs mentioned

• BTD-001

Snippet

Sponsor: Balance Therapeutics | Conditions: Idiopathic Hypersomnia, Narcolepsy Without Cataplexy | Phase 2 | Status: COMPLETED